RxDoctor Payments Data

Valery Muenyi, MD

Gastroenterology · Jacksonville, FLNPI 1427476852

Payments from drug & device makers

$2,666in general payments, 2019–2025

Across 144 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Janssen Scientific Affairs, LLC$218
  • Pfizer$174
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$167
  • Gilead$153
  • Madrigal Pharmaceuticals$133
  • plus $549 from 10 others

What the payments were for

  • Food & beverage$2,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,666 in reported general payments places this provider in the 40th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida

Medicare billing

Part B allowed, 2024
$153,410
Medicare patients
299
Services billed
1,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$147,730
LinzessLinaclotide14$12,111
Esomeprazole Magnesium33$3,017
SutabSod Sulf/Pot Chloride/Mag Sulf17$2,684
Pantoprazole Sodium215$2,077
ClinisolParenteral Amino Acid 15% No.511$1,435
Omeprazole101$1,153
CholestyramineCholestyramine (With Sugar)17$1,113
Dicyclomine Hcl46$909
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl50$828
Ondansetron OdtOndansetron28$709
Sucralfate24$610
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates11$608
Clarithromycin20$462
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl11$206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,272$12,11114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →